For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Replimune Group Inc’s stock clocked out at $7.21, up 0.84% from its previous closing price of $7.15. In other words, the price has increased by $0.84 from its previous closing price. On the day, 1.14 million shares were traded. REPL stock price reached its highest trading level at $7.33 during the session, while it also had its lowest trading level at $7.14.
Ratios:
To gain a deeper understanding of REPL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.40 and its Current Ratio is at 12.40. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.17.
On November 19, 2021, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $52.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 16 ’23 when Xynos Konstantinos sold 7,313 shares for $10.92 per share. The transaction valued at 79,858 led to the insider holds 112,714 shares of the business.
Sarchi Christopher sold 5,255 shares of REPL for $57,385 on Nov 16 ’23. The Chief Commercial Officer now owns 72,245 shares after completing the transaction at $10.92 per share. On Sep 12 ’23, another insider, Esposito Pamela, who serves as the Chief Business Officer of the company, sold 300 shares for $20.00 each. As a result, the insider received 6,000 and left with 263,436 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, REPL now has a Market Capitalization of 442606048 and an Enterprise Value of 52065936.
Stock Price History:
The Beta on a monthly basis for REPL is 1.22, which has changed by -0.5667067 over the last 52 weeks, in comparison to a change of 0.2160933 over the same period for the S&P500. Over the past 52 weeks, REPL has reached a high of $24.81, while it has fallen to a 52-week low of $5.89. The 50-Day Moving Average of the stock is -9.47%, while the 200-Day Moving Average is calculated to be -44.06%.
Shares Statistics:
It appears that REPL traded 1.34M shares on average per day over the past three months and 802530 shares per day over the past ten days. A total of 56.68M shares are outstanding, with a floating share count of 44.47M. Insiders hold about 27.56% of the company’s shares, while institutions hold 92.54% stake in the company. Shares short for REPL as of 1711584000 were 7736754 with a Short Ratio of 5.77, compared to 1709164800 on 6480214. Therefore, it implies a Short% of Shares Outstanding of 7736754 and a Short% of Float of 14.37.
Earnings Estimates
The current assessment of Replimune Group Inc (REPL) involves the perspectives of 8 analysts closely monitoring its market dynamics.On average, analysts expect EPS of -$0.79 for the current quarter, with a high estimate of -$0.7 and a low estimate of -$0.86, while EPS last year was -$0.74. The consensus estimate for the next quarter is -$0.8, with high estimates of -$0.75 and low estimates of -$0.86.
Analysts are recommending an EPS of between -$3.15 and -$3.53 for the fiscal current year, implying an average EPS of -$3.27. EPS for the following year is -$3.03, with 8 analysts recommending between -$2.51 and -$3.4.
